Welcome to our dedicated page for Arrow Finl SEC filings (Ticker: AROW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Arrow Financial Corporation (NASDAQ: AROW) SEC filings page provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Arrow is a New York corporation and bank holding company for Arrow Bank National Association and other subsidiaries, and it uses SEC reports and current reports on Form 8-K to communicate material information to investors.
Through this page, users can review Arrow’s current reports on Form 8-K that address topics such as quarterly financial results, dividend declarations, share repurchase authorizations, appointments of directors and executive arrangements, and updates on shareholder derivative litigation. For example, recent 8-K filings describe the preliminary court approval of a stipulation and agreement of settlement resolving a shareholder derivative complaint, the appointment of a new director to the Board of Directors, and quarterly cash dividend declarations.
In addition to 8-Ks, investors typically look to Arrow’s annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of net interest income, loan and deposit balances, credit quality, capital ratios and risk factors relevant to a commercial banking organization. These filings complement the earnings releases that Arrow furnishes as 8-K exhibits and reference in its news.
On Stock Titan, AI-powered tools can help interpret lengthy filings by highlighting key sections related to capital strength, allowance for credit losses, nonperforming assets, regulatory capital ratios and the financial impact of any disclosed settlements or non-core items. Users can also monitor insider and governance-related disclosures, such as director appointments and professional services agreements with former executives, as reported under Item 5.02 of Form 8-K. This makes it easier to follow how Arrow’s regulatory reporting reflects its banking, insurance and investment activities over time.
Arrow Financial Corp director Darrin Jahnel received a small equity award in the form of restricted stock. On January 28, 2026, he acquired 69 shares of Arrow Financial common stock at $32.43 per share, held directly.
The 69 restricted shares vest in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029, aligning his compensation with the company’s long-term performance. Following this grant, Jahnel beneficially owns 69 common shares.
Arrow Financial Corp director Mark Behan reported a grant of 818 shares of common stock on January 28, 2026. The shares are restricted stock that vest in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029 at a grant price of $32.43 per share.
After this award, Behan directly beneficially owns 12,709 shares, which include 95 shares acquired under the Company's DRIP since October 8, 2025. These DRIP acquisitions were not previously required to be reported on a Form 4.
Arrow Financial Corp director Tenee R. Casaccio received an award of 818 shares of common stock on January 28, 2026 at $32.43 per share. These restricted shares vest in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029.
After this grant and including 231 shares previously acquired through the company’s dividend reinvestment plan, Casaccio beneficially owns 27,591 Arrow Financial shares directly.
Arrow Financial Corp director Gregory J. Champion received a grant of 818 shares of common stock on January 28, 2026. The shares were awarded at a price of $32.43 per share and are structured as restricted stock.
The restricted stock vests in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029, tying the award to continued service over time. After this grant, Champion beneficially owns 10,943 shares directly, which includes 84 shares acquired through the company’s dividend reinvestment plan.
Arrow Financial Corp reported that director James M. Dawsey received an award of 818 shares of common stock on January 28, 2026 at $32.43 per share. The grant is in the form of restricted stock that vests in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029. Following this grant and including 169 shares acquired under the company’s dividend reinvestment plan since October 8, 2025, Dawsey beneficially owns 19,461 shares of Arrow Financial common stock, held directly.
Arrow Financial Corp director David G. Kruczlnicki received a grant of 818 shares of common stock on January 28, 2026 at $32.43 per share. After this award, he directly beneficially owned 60,134 shares. The footnote states this restricted stock vests in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029.
Arrow Financial Corp director Elizabeth Miller reported a stock award of 818 shares of common stock on January 28, 2026 at $32.43 per share. The filing notes this grant is restricted stock that vests in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029.
After this award, Miller directly holds 39,985 shares of Arrow Financial common stock, which includes 146 shares acquired under the Company's DRIP since October 8, 2025. An additional 5,847 shares are held indirectly by Miller Family Partnership, LP, for which she disclaims beneficial ownership.
Arrow Financial Corp director Philip C. Morris received a grant of restricted common stock. On January 28, 2026, he acquired 818 shares at $32.43 per share, increasing his directly held stake to 7,160 shares. The restricted stock will vest in three equal installments on January 28 of 2027, 2028, and 2029.
Arrow Financial Corp director reports restricted stock grant. Director Raymond F. O'Conor acquired 818 shares of Arrow Financial common stock on January 28, 2026 at $32.43 per share as a stock award. After this grant, he beneficially owns 30,519 common shares directly.
The 818 restricted shares vest in three equal installments on January 28 of 2027, 2028, and 2029, meaning the director earns full rights to the shares gradually over three years.
Arrow Financial Corp director Colin L. Read reported receiving an award of 818 shares of Arrow Financial common stock on January 28, 2026 at a value of $32.43 per share. After this grant, he directly holds 30,150 common shares.
The 818 restricted shares vest in three equal installments on January 28, 2027, January 28, 2028, and January 28, 2029. The filing also notes 3,020 shares held indirectly by his wife, for which he disclaims beneficial ownership.